who makes glp-1 drugs FDA says that the shortage is over GLP-1 weight loss drug study

Evaluation of the effects of exenatide administration in patients with type 2 diabetes with worsened glycemic control caused by glucocorticoid therapy

Obesity, unfavourable lifestyle and genetic risk of type 2 diabetes: A case-cohort study

PeerJ 12, e17891

10.1016/j.clinre.2013.10.013 59

Discussion In this study, leveraging non-viral LNPs and the HITI-mediated genome editing method, we engineered a secretion-enabled Exe4 peptide, scExe4, and developed an in vivo scExe4 peptide production reservoir via knock-in into mouse liver cells

Reported semaglutide overdose adverse events include gastrointestinal effects (e.g., nausea, vomiting, abdominal pain), fainting, headache, migraine, dehydration, acute pancreatitis and gallstones